Stream 2 Session #13: Artificial Intelligence & Continuous Glucose Monitoring Therapy
Tracks
Meeting Room 105 & 106
| Thursday, August 20, 2026 |
| 11:00 AM - 12:30 PM |
| Meeting Room 105 & 106 (Level 1) |
Details
This 90 minute symposium will examine the role of artificial intelligence (AI) & continuous glucose monitoring (CGM) from clinical, system and education perspectives. The session will progress from current evidence and unmet clinical need in T2D to the practical considerations required for safe, responsible implementation at scale, including implications for clinicians, services and education.
Speaker
Dr Kirsten Neal
Endocrinologist & General Medicine Physician
Northern Beaches Hospital
Why CGM in T2D, and why AI now? AI enabled CGM: what problem is it actually solving?
11:00 AM - 11:20 AMBiography
Sally Double
Registered Nurse / Credentialed Diabetes Educator
Melbourne Diabetes Educators
From insight to action: practical use of AI enabled CGM
11:20 AM - 11:45 AMBiography
Prof Partha Kar
Endocrinologist
Australasian Medical and Scientific Ltd
Scaling AI enabled CGM: trust, accuracy and system readiness
11:45 AM - 12:10 PMBiography
All Speakers
Panel & Close
12:10 PM - 12:30 PMBiography
Dr Kirsten Neal
Endocrinologist & General Medicine Physician
Northern Beaches Hospital
Chairperson
Biography
